In partnership with
NVIDIA's Founder Says Farmers Should Absolutely Use AI
“If I were a farmer, I would absolutely use AI.”
That’s Jensen Huang, founder and CEO of NVIDIA.
And he's pointing to one of AI’s biggest untapped opportunities: Farming. It’s an industry facing mounting pressure to produce more with less and it’s still massively under-automated.
DIT AgTech brings AI, nutrition automation, and real-time data to livestock production, helping ranchers boost productivity and get more from every animal.
And it’s already proven in one of the world's toughest livestock environments:
500+ units deployed
370,000 head of livestock on the platform
Up to 55% higher daily weight gain
Now expanding into the U.S. and Brazil, DIT AgTech is targeting a 300M+ head cattle market. And the biggest barrier to adoption? Gone. Ranchers get the technology for free when they sign up for a three-year nutrition plan.
DIT AgTech can scale adoption faster, which means more data and more recurring revenue.
Invest before this early-stage opportunity gets harder to access.
𝘐𝘯 𝘮𝘢𝘬𝘪𝘯𝘨 𝘢𝘯 𝘪𝘯𝘷𝘦𝘴𝘵𝘮𝘦𝘯𝘵 𝘥𝘦𝘤𝘪𝘴𝘪𝘰𝘯, 𝘪𝘯𝘷𝘦𝘴𝘵𝘰𝘳𝘴 𝘮𝘶𝘴𝘵 𝘳𝘦𝘭𝘺 𝘰𝘯 𝘵𝘩𝘦𝘪𝘳 𝘰𝘸𝘯 𝘦𝘹𝘢𝘮𝘪𝘯𝘢𝘵𝘪𝘰𝘯 𝘰𝘧 𝘵𝘩𝘦 𝘪𝘴𝘴𝘶𝘦𝘳 𝘢𝘯𝘥 𝘵𝘩𝘦 𝘵𝘦𝘳𝘮𝘴 𝘰𝘧 𝘵𝘩𝘦 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘵𝘩𝘦 𝘮𝘦𝘳𝘪𝘵𝘴 𝘢𝘯𝘥 𝘳𝘪𝘴𝘬𝘴 𝘪𝘯𝘷𝘰𝘭𝘷𝘦𝘥. 𝘋𝘐𝘛 𝘈𝘨𝘛𝘦𝘤𝘩 𝘩𝘢𝘴 𝘧𝘪𝘭𝘦𝘥 𝘢 𝘍𝘰𝘳𝘮 𝘊 𝘸𝘪𝘵𝘩 𝘵𝘩𝘦 𝘚𝘦𝘤𝘶𝘳𝘪𝘵𝘪𝘦𝘴 𝘢𝘯𝘥 𝘌𝘹𝘤𝘩𝘢𝘯𝘨𝘦 𝘊𝘰𝘮𝘮𝘪𝘴𝘴𝘪𝘰𝘯 𝘪𝘯 𝘤𝘰𝘯𝘯𝘦𝘤𝘵𝘪𝘰𝘯 𝘸𝘪𝘵𝘩 𝘪𝘵𝘴 𝘰𝘧𝘧𝘦𝘳𝘪𝘯𝘨, 𝘢 𝘤𝘰𝘱𝘺 𝘰𝘧 𝘸𝘩𝘪𝘤𝘩 𝘮𝘢𝘺 𝘣𝘦 𝘰𝘣𝘵𝘢𝘪𝘯𝘦𝘥 𝘩𝘦𝘳𝘦: https://bit.ly/4bzuWCi
LONGEVITY LATEST ISSUE 30 · 30 SEPTEMBER 2026
LONGEVITY LATEST
The Evidence-Based Edge on Living Longer and Better
Issue 30 · The Scan and the Break · 30 September 2026
WELCOME
Welcome
More than half of the older women who broke a hip in the Study of Osteoporotic Fractures did not have osteoporosis on their scan. Their T-scores sat above the line that usually triggers treatment.
The scan wasn’t wrong. It was answering a narrower question than the one they needed answered. Never had one? The better question is open to you too: what’s your ten-year fracture risk?
Last week’s muscle story carries straight over. Weight loss draws on bone as well as muscle, and the new drugs can speed that up. This week we grade three ways to protect bone, and test the idea that more vitamin D means stronger bones.
SPOTLIGHT
Density, risk and a fall are different numbers
Measure | What it tells you | What it cannot tell you |
T-score (DXA scan) | How dense your hip or spine is compared with a healthy young adult. −2.5 or lower counts as osteoporosis. | How well built the bone is, whether you will fall, or your own chance of a fracture. |
10-year fracture risk (FRAX or QFracture) | Your probability of a major or hip fracture from age, sex, past fractures, family history, steroids, smoking and alcohol. Density is optional in FRAX. | Whether weight loss or a new drug is changing that risk right now. |
Falls and function (falls history, chair stands) | How likely you are to meet a fracture-sized force. | How strong the bone is when you land. |
Density still matters: the lower the T-score, the higher each person’s risk. But far more people sit in the osteopenia band than below −2.5, so that’s where most fractures happen in absolute numbers. In SOF, 54% of 243 hip fractures among 8,065 women aged 65 or over were in women without osteoporosis at baseline. NICE’s July 2026 update (NG259) keeps the order: risk first, then a scan where it sharpens the answer.
Wainwright et al. SOF. J Clin Endocrinol Metab (2005) · Siris et al. NORA. Arch Intern Med (2004) · NICE NG259 summary. Royal Osteoporosis Society (2026)
Density is one input. Fracture risk is the number that should drive decisions.
THIS WEEK’S ANALYSIS
Top 3 Interventions Under the Microscope
The grades judge evidence for protecting bone and preventing fractures, not for adding years.
Bone-evidence grades: A = trials show fewer fractures; B = trials show protected bone density, fracture benefit unproven; C = early or single-trial human data; D = insufficient or conflicting evidence.
1. Load the skeleton while losing weight | Grade B
Lift, and add impact if your joints allow, especially while losing weight. It’s the strongest non-drug option, though the trials disagree more than I’d like.
Why. Bone remodels to the load it carries; lose 15 kg and the skeleton reads it as a smaller building needing less scaffolding. In older dieters losing about 10% of their weight, hip density fell 0.7% with resistance training and 2.6% with aerobic training. In a Danish trial of 195 adults, liraglutide alone lowered hip and spine density against exercise alone, while exercise plus liraglutide lost the most weight, around 17 kg, and kept its hip and spine density. LIFTMOR set the ceiling: eight months of supervised heavy lifting and jumping raised spine density in 101 postmenopausal women with low bone mass.
The limit. INVEST in Bone Health (150 older adults, 2025) found that neither lifting nor a weighted vest kept more hip density than dieting alone, and none of these weight-loss trials counted fractures. B, and not a comfortable one. With osteoporosis or a spinal fracture, learn heavy lifts with a physiotherapist.
Armamento-Villareal et al. JBMR (2020) · Jensen et al. JAMA Netw Open (2024) · Watson et al. LIFTMOR. JBMR (2018) · Beavers et al. INVEST. JAMA Netw Open (2025)
2. Treat the risk, not the T-score | Grade A
If your fracture risk is high, ask about treatment even when the scan says “only” osteopenia. This is the one entry here with fracture evidence.
This is the trial that should retire the idea that osteopenia means “fine”. In Auckland, 2,000 women aged 65 or over with osteopenia received zoledronate or placebo infusions every 18 months for six years. Fragility fractures struck 122 women on the drug and 190 on placebo (HR 0.63), and vertebral fractures fell by more than half. About 15 women needed treating for six years to prevent one fracture. The funding was public, from New Zealand’s Health Research Council.
Expect a day or two of flu-like aches after the first infusion. Kidney function needs checking first, and the rare jaw and thigh-bone complications deserve a conversation. Only older women took part; for men and younger women it’s extrapolation.
3. Weighted vests | Grade D
Fine for fitness. Don’t buy one for your bones.
Fair warning: I wanted this one to work. The logic is neat: replace the weight you lose so the skeleton never notices. In INVEST, participants wore a vest for about seven hours a day, carrying roughly 80% of the weight they had shed, for a year. Hip density held no better than with dieting alone.
A later split by sex, so far only a conference abstract, found slightly less hip loss in women and more in men. A hypothesis, not a shopping list.
HYPE CHECK
“More vitamin D, stronger bones”
The claim. High-dose vitamin D protects your skeleton, so more is better, and a big dose now and then saves remembering a daily pill.
The missing step. In VITAL, 25,871 adults aged 50 and over took 2,000 IU a day or placebo for a median of 5.3 years. Fracture rates didn’t differ. In an Australian trial of 2,256 women aged 70 or over, a single 500,000 IU dose each autumn produced 15% more falls and 26% more fractures than placebo.
The big yearly dose meant to prevent fractures produced more of them.
That doesn’t make vitamin D useless. Genuine deficiency softens bone, and most VITAL participants started with adequate levels, so the trial tells us about topping up, not rescuing. The 2024 Endocrine Society guideline advises against routine testing and above-standard doses in healthy adults under 75, and favours daily doses over large boluses.
LeBoff et al. VITAL. NEJM (2022) · Sanders et al. JAMA (2010) · Demay et al. Endocrine Society guideline (2024)
Our verdict. Take a standard daily dose if you’re over 75, rarely outdoors or flagged by your clinician; in the UK, the NHS suggests 10 micrograms a day through autumn and winter for everyone. Skip megadoses and yearly boluses. Put the money towards a pair of dumbbells, which at least have trial evidence for bone density behind them.
IN BRIEF · NEW RESEARCH
A 94% headline from ten patients. A phase 1 trial in Cell (11 September) gave ten women aged 51 to 72 with advanced osteoporosis one infusion of their own bone-marrow stromal cells, engineered to home to bone. In the first two years, fractures across the group fell from about eight a year to 0.5, the source of the 94%. Over the whole follow-up the rate per patient fell from 0.54 a year to 0.11, about 80% lower, and density rose. There was no control group, some women were also on the bone-building drug teriparatide, and fracture rates measured from a bad patch tend to fall anyway. Clever biology that deserves a proper trial. It’s an experimental intervention, not an established treatment, and nothing like what private stem-cell clinics sell.
THIS WEEK’S DEEP DIVE
What a T-Score Can’t See
Older adults who dieted and exercised for a year lost hip density on DXA, yet CT estimates of bone strength held. Less density, same estimated strength.
The companion explains why weight loss thins bone, when the scan overstates or misses the change, what the semaglutide data actually show, and how big a change on your own scan must be before it means anything.
BIOHACKING CORNER · THE SHORT VERSION
No scan yet? Start with the free FRAX calculator and leave the density box empty; NICE recommends that order anyway. Had a scan? Find the femoral neck result on your report, the only site FRAX uses, and run the calculator again with it. If you’re already on a bone drug, FRAX can’t tell you whether it’s working, so read any result with your clinician. And if you’ve broken a bone in a minor fall, that outranks any T-score: ask for a fracture risk assessment.
My rule: compare scans only from the same machine, and treat any change smaller than that centre’s least significant change as unproven, not absent. If you’re over 65 or have other risk factors and are starting a weight-loss drug, ask whether a baseline scan makes sense.
READER PULSE
Two yes-or-no questions: have you ever had a DXA scan, and did anyone give you a ten-year fracture risk alongside the T-score? Reply with your two answers. I suspect the second will be “no” more often than it should be.
CLOSING
Load the frame you’ll land on
Muscle was last week’s reserve; bone is the frame underneath it. Density measures part of that frame, fracture risk measures more, and loading plus the right drug for the right person are the tools with evidence. Weight loss is worth doing for many people. Do it with the skeleton loaded.
Next week: falls, the event that turns fragile bone into a fracture, and the balance training with the strongest trial record.
Stay curious and stay healthy!
Christian Thomsen, Editor
Longevity Latest is published weekly by FrontWave Media Ltd. Educational content, not personal medical advice. Do not start, stop or change a bone or weight-loss medication on the basis of this issue. With osteoporosis, a previous fracture or balance problems, check with a clinician before starting heavy or impact training.
Sources and reading notes
Evidence checked through 25 September 2026. Of the three graded interventions, only zoledronate has randomised fracture evidence; the exercise, vest and GLP-1 data reviewed here rely on density and bone markers. The stem-cell trial was uncontrolled.
Beavers et al. INVEST in Bone Health. JAMA Network Open (2025) · Sex-stratified analysis. Innovation in Aging (2025)
Demay et al. Endocrine Society vitamin D guideline (2024) · Moraleda et al. Stem-cell therapy in advanced osteoporosis. Cell (2026)
© 2026 FrontWave Media Ltd · Longevity Latest
Is Your Training Data Actually Model-Ready?
DNSMOS gives you a score, not whether that data fits your model. Treat it as pass/fail and you'll train on audio that looks clean but hurts performance, while tossing good data for no reason. Voices' CTO DJ Jalali just published a white paper with the four-step framework the team uses to set internal thresholds instead.